IDEAYA Biosciences Says $941.4M Of Cash, Cash Equivalents And Marketable Securities As Of March-End, Anticipated To Fund Operations Into 2028
IDEAYA Biosciences Says $941.4M Of Cash, Cash Equivalents And Marketable Securities As Of March-End, Anticipated To Fund Operations Into 2028
IDEAYA Biosciences表示，截至3月底，有9.414億美元的現金、現金等價物和有價證券，預計將爲2028年的運營提供資金
IDEAYA Biosciences Says $941.4M Of Cash, Cash Equivalents And Marketable Securities As Of March-End, Anticipated To Fund Operations Into 2028
IDEAYA Biosciences表示，截至3月底，有9.414億美元的現金、現金等價物和有價證券，預計將爲2028年的運營提供資金
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。